Just heard from the CEO, James Wang. He stated the recent dilution occurred because the company's creditors, who entered into debt agreements with the company years ago when it was a Chinese Biotech, converted their debt into equity. He did not state if they are done selling. Also, expect the 10-k at the end of the month and expect a business update soon.
Market Data 
Markets 
AI
